Clinical perspectives of emerging pathogens in bleeding disorders
暂无分享,去创建一个
M. Diamond | P. Simmonds | S. Bozzette | W. Powderly | B. Ritchie | S. Stanley | M. von Depka | M. Tapper | C. Ludlam | M. Koerper | R. Kulkarni | J. Siegel
[1] M. Turner,et al. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products , 2006, British journal of haematology.
[2] Anthony J McMichael,et al. Social and environmental risk factors in the emergence of infectious diseases , 2004, Nature Medicine.
[3] M. Head,et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.
[4] Y. Chan,et al. Recombinant Human Enterovirus 71 , 2004, Emerging infectious diseases.
[5] J. Montaner,et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. , 2004, The New England journal of medicine.
[6] P. Volberding,et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. , 2004, The New England journal of medicine.
[7] J. Rockstroh,et al. HIV and hepatitis C virus co-infection. , 2004, The Lancet. Infectious diseases.
[8] J. Wagenaar,et al. Dengue: an arthropod-borne disease of global importance , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[9] D. Butler. Fatal fruit bat virus sparks epidemics in southern Asia , 2004, Nature.
[10] P. Klapper,et al. Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[11] C. Thio. Management of chronic hepatitis B in the HIV-infected patient. , 2004, The AIDS reader.
[12] M. Enserink. Nipah Virus (or a Cousin) Strikes Again , 2004, Science.
[13] S. Darby,et al. The impact of HIV on mortality rates in the complete UK haemophilia population , 2004, AIDS.
[14] J Mackenzie,et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.
[15] I. Vorberg,et al. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. , 2004, The Journal of infectious diseases.
[16] R. Dodd,et al. Emerging infectious threats to the blood supply. , 2004, Annual review of medicine.
[17] Shin-Ru Shih,et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. , 2004, JAMA.
[18] T. Solomon,et al. Neurovirulence and host factors in flavivirus encephalitis--evidence from clinical epidemiology. , 2004, Archives of virology. Supplementum.
[19] M. Enserink. Emerging infectious diseases. Nipah virus (or a cousin) strikes again. , 2004, Science.
[20] B. Ritchie. Tissue archives to track blood borne pathogens in people receiving blood products. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[21] G. Pomper,et al. Risks of transfusion-transmitted infections: 2003. , 2003, Current opinion in hematology.
[22] X. L. Liu,et al. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.
[23] J. Sejvar,et al. West Nile virus in the United States: an update on an emerging infectious disease. , 2003, American family physician.
[24] P. Simmonds,et al. Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors , 2003, Transfusion.
[25] J. Astermark,et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.
[26] S. Kleinman,et al. Current and emerging infectious risks of blood transfusions. , 2003, JAMA.
[27] A. Boner,et al. TT Virus in the Nasal Secretions of Children with Acute Respiratory Diseases: Relations to Viremia and Disease Severity , 2003, Journal of Virology.
[28] A. Vats,et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults1 , 2003, Transplantation.
[29] Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.
[30] Manuel Amador,et al. Texas Lifestyle Limits Transmission of Dengue Virus , 2003, Emerging infectious diseases.
[31] Joshua Lederberg,et al. Microbial Threats to Health: Emergence, Detection, and Response , 2003 .
[32] N. Komar. West Nile virus: epidemiology and ecology in North America. , 2003, Advances in virus research.
[33] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.
[34] J. Goedert,et al. Factors predictive of death among HIV‐uninfected persons with haemophilia and other congenital coagulation disorders , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[35] B. Biggerstaff,et al. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City , 2002, Transfusion.
[36] S. Hino. TTV, a new human virus with single stranded circular DNA genome , 2002, Reviews in medical virology.
[37] S V Tiroumourougane,et al. Japanese viral encephalitis , 2002, Postgraduate medical journal.
[38] Kazuya Nakamura,et al. Feline Host Range of Canine parvovirus: Recent Emergence of New Antigenic Types in Cats , 2002, Emerging infectious diseases.
[39] M. Chamberland,et al. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] Kuender D Yang,et al. Clinical Manifestations and Laboratory Assessment in an Enterovirus 71 Outbreak in Southern Taiwan , 2002, Scandinavian journal of infectious diseases.
[41] D. Vaughn,et al. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. , 2002, Current topics in microbiology and immunology.
[42] B. Sampson,et al. West Nile Encephalitis , 2001, Annals of the New York Academy of Sciences.
[43] R. Colvin,et al. BK virus in solid organ transplant recipients: an emerging syndrome. , 2001, Transplantation.
[44] I. Macgregor,et al. Immunoassay of human plasma cellular prion protein , 2001, Transfusion.
[45] A. Dobson,et al. Emerging infectious pathogens of wildlife. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[46] P. Giangrande,et al. Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia. , 2001 .
[47] P. Giangrande,et al. Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[48] Natale Scaramozzino,et al. Comparison of Flavivirus Universal Primer Pairs and Development of a Rapid, Highly Sensitive Heminested Reverse Transcription-PCR Assay for Detection of Flaviviruses Targeted to a Conserved Region of the NS5 Gene Sequences , 2001, Journal of Clinical Microbiology.
[49] R. Rubenstein,et al. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins , 2001, Transfusion.
[50] Hoots Wk. History of plasma-product safety. , 2001 .
[51] T. Solomon,et al. Dengue and other emerging flaviviruses. , 2001, The Journal of infection.
[52] W. Hoots. History of plasma-product safety. , 2001, Transfusion medicine reviews.
[53] Berger. Progressive Multifocal Leukoencephalopathy. , 2020, Current treatment options in neurology.
[54] J. Platt. Zoonosis in xenotransplantation. , 2000, Transplantation proceedings.
[55] A. Degener,et al. Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. , 2000, The Journal of general virology.
[56] D. U. Mehnert,et al. Molecular characterization of canine parvovirus in Brazil by polymerase chain reaction assay. , 2000, Veterinary microbiology.
[57] L. Cowan,et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. , 2000, Blood.
[58] H. Field,et al. Nipah virus: a recently emergent deadly paramyxovirus. , 2000, Science.
[59] H. Westbury. Hendra virus disease in horses. , 2000, Revue scientifique et technique.
[60] H. Ning,et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. , 1999, The Pediatric infectious disease journal.
[61] T. Yeh,et al. Neurologic complications in children with enterovirus 71 infection. , 1999, The New England journal of medicine.
[62] C. Parrish. Host range relationships and the evolution of canine parvovirus. , 1999, Veterinary microbiology.
[63] H. Ishiko,et al. Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. , 1999, Pediatric neurology.
[64] R. Weiss,et al. Host range and interference studies of three classes of pig endogenous retrovirus. , 1999, Journal of virology.
[65] DavidJ. Evans,et al. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.
[66] A. Vandamme,et al. The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses. , 1996, The Journal of general virology.
[67] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[68] U. Zweifel,et al. United Nations Environment Programme , 2005, Essential Concepts of Global Environmental Governance.
[69] M. Mochizuki,et al. Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan. , 1993, Veterinary microbiology.
[70] C. Parrish,et al. Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo , 1992, Journal of virology.
[71] L. Evans,et al. Direct determination of the point mutation rate of a murine retrovirus , 1992, Journal of virology.
[72] G. Baatz. [Ten years of clinical experiences with canine parvovirus infection CPV-2 infection)]. , 1992, Tierarztliche Praxis.
[73] R. Rico-Hesse,et al. Venezuelan haemorrhagic fever , 1991, The Lancet.
[74] Hilgartner Mw. The need for recombinant factor VIII: historical background and rationale. , 1991 .
[75] M. Hilgartner. The need for recombinant factor VIII: historical background and rationale. , 1991, Seminars in hematology.
[76] R. Holman,et al. Human T-Lymphotropic Retrovirus Type III / Lymphadenopathy-Associated Virus Antibody: Association With Hemophiliacs' Immune Status and Blood Component Usage , 1985 .
[77] A. Landay,et al. Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings. , 1983, Annals of internal medicine.
[78] Bastianello Ss. Canine parvovirus myocarditis: clinical signs and pathological lesions encountered in natural cases. , 1981 .
[79] S. Bastianello. Canine parvovirus myocarditis: clinical signs and pathological lesions encountered in natural cases. , 1981, Journal of the South African Veterinary Association.
[80] H. Hoogstraal,et al. An epizootic of Rift Valley fever in Egypt in 1977 , 1979, Veterinary Record.